PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17431132-0	2007	Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.	Imatinib Mesylate	138-155	nibrin	Homo sapiens	28-32	
17431132-0	2007	Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.	Imatinib Mesylate	138-155	MRE11 homolog, double strand break repair nuclease	Homo sapiens	76-81	
17431132-0	2007	Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.	Imatinib Mesylate	138-155	RAD50 double strand break repair protein	Homo sapiens	82-87	
17431132-0	2007	Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.	Imatinib Mesylate	138-155	nibrin	Homo sapiens	88-92	
17431132-0	2007	Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.	Imatinib Mesylate	138-155	BCR activator of RhoGEF and GTPase	Homo sapiens	164-167	
17431132-4	2007	Enhanced ATM kinase-dependent phosphorylation of Nbs1 on serine 343 (S343) in response to genotoxic treatment was detected in leukemia cells expressing BCR/ABL and other FTKs in comparison to normal counterparts stimulated with IL-3, GM-CSF, and SCF.	Serine	57-63	nibrin	Homo sapiens	49-53	
17431132-4	2007	Enhanced ATM kinase-dependent phosphorylation of Nbs1 on serine 343 (S343) in response to genotoxic treatment was detected in leukemia cells expressing BCR/ABL and other FTKs in comparison to normal counterparts stimulated with IL-3, GM-CSF, and SCF.	Serine	57-63	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	152-159	
17431132-4	2007	Enhanced ATM kinase-dependent phosphorylation of Nbs1 on serine 343 (S343) in response to genotoxic treatment was detected in leukemia cells expressing BCR/ABL and other FTKs in comparison to normal counterparts stimulated with IL-3, GM-CSF, and SCF.	Serine	57-63	interleukin 3	Homo sapiens	228-232	
17431132-4	2007	Enhanced ATM kinase-dependent phosphorylation of Nbs1 on serine 343 (S343) in response to genotoxic treatment was detected in leukemia cells expressing BCR/ABL and other FTKs in comparison to normal counterparts stimulated with IL-3, GM-CSF, and SCF.	Serine	57-63	colony stimulating factor 2	Homo sapiens	234-240	
17431132-4	2007	Enhanced ATM kinase-dependent phosphorylation of Nbs1 on serine 343 (S343) in response to genotoxic treatment was detected in leukemia cells expressing BCR/ABL and other FTKs in comparison to normal counterparts stimulated with IL-3, GM-CSF, and SCF.	Serine	57-63	KIT ligand	Homo sapiens	246-249	
17431132-6	2007	Interestingly, inhibition of Nbs1 phosphorylation by S343A mutant enhanced the antileukemia effect of the combination of imatinib and genotoxic agent.	Imatinib Mesylate	121-129	nibrin	Homo sapiens	29-33